| Literature DB >> 27095514 |
Pradeep S Jadhavar1, Tejas M Dhameliya1, Maulikkumar D Vaja1, Dinesh Kumar1, Jonnalagadda Padma Sridevi2, Perumal Yogeeswari2, Dharmarajan Sriram2, Asit K Chakraborti3.
Abstract
2-Styrylquinazolones are reported as a novel class of potent anti-mycobacterial agents. Forty-six target compounds have been synthesized using one pot reaction involving isatoic anhydride, amine, and triethyl orthoacetate followed by aldehyde to construct the 2-styrylquinazolone scaffold. The anti-mycobacterial potency of the compounds was determined against H37Rv strain. Twenty-six compounds exhibited anti-Mtb activity in the range of 0.40-6.25μg/mL. Three compounds 8c, 8d and 8ab showed MIC of 0.78μg/mL and were found to be non-toxic (<50% inhibition at 50μg/mL) to HEK 293T cell lines with the therapeutic index >64. The most potent compound 8ar showed MIC of 0.40μg/mL with the therapeutic index >125. An early structure activity relationship for this class of compounds has been established. The computational studies indicate the possibility of these compounds binding to the penicillin binding proteins (PBPs).Entities:
Keywords: 2-Styrylquinazolone; Anti-TB agents; H(37)Rv strain; SAR; Tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 27095514 DOI: 10.1016/j.bmcl.2016.04.012
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823